Disclosures for "Early-onset Creutzfeldt-Jakob Disease with Prolonged Course and Atypical Features After COVID-19 Illness"
-
Mr. Chang has nothing to disclose.
-
The institution of Dr. Cahill has received research support from Roche / Genentech. Dr. Cahill has received publishing royalties from a publication relating to health care.
-
Dr. Rizvi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serono Roche Bristol Myers . Dr. Rizvi has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Na.